Built by a 17-year enterprise software firm.

Where the product is today.

• Seven AI agents that read notes, code, check claims, flag denial risk, draft appeals, reconcile drugs and audit. A person reviews the output.
• Three secure connectors that work inside real customer systems: OncoEMR chart retrieval, AdvancedMD charge posting and eTactics eligibility checks.
• A multi-practice platform for billing agencies with a plan and prepaid wallet for each practice, module access, roles, a team productivity report and a billing page.
• A nightly billing scorecard. It compares each claim as ClaimVise coded it, as your reviewer finalized it and as the practice charged it. The ClaimVise team switches it on for an agency.
• Rules learned from reviewer changes. When reviewers keep making the same fix and the practice's own charges agree, ClaimVise can turn it into a narrow rule for that practice. It is off by default, admins can see and suspend any rule, and the AI model itself is not retrained.
• CMS reference data refreshed every quarter: NCCI and MUE edits, the physician fee schedule, drug payment limits, HCPCS and ICD-10-CM. The October 2026 quarterly datasets are loaded, and the 15 HCPCS codes CMS ended on 30 September 2026 are closed.
• Guardrails built in. A charge is never filled in with a guess. A tamper-evident audit log records each decision. Every release of the coding engine is tested against real notes before it ships.

ClaimVise is built to work across specialties. The coding engine and the CMS reference data cover them all. We started in hematology and oncology, and that is where our testing runs deepest. Other specialties are added one at a time: each gets its own rules and runs in shadow beside the standard result on real notes. A qualified coder must review and sign off the rules before routine use.

What comes next.

First is the move of the whole platform to AWS, with a target of 30 November 2026. It is in progress, not finished. Today the app and database run on a hosting provider's servers in France, and AI processing runs on AWS in the US. After that come clearinghouse submission, live remittance posting, and integrations with Availity, eClinicalWorks, OmniMD and Meditab (all planned). Later comes AR follow-up and prior authorization. The roadmap lists every item and its status.

For investors.

We are talking with early-stage investors who know healthcare operations and vertical AI. If that is you, write to Chirag at chirag@innodel.com. We will walk you through the product, the roadmap and where the business stands today.